These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 35205356)

  • 21. [State of the art of pharmacogenetic diagnostics in drug therapy].
    Kirchheiner J; Seeringer A; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Pharmacogenetic Lab-on-Chip Assay Based on the In-Check Technology to Screen for Genetic Variations Associated to Adverse Drug Reactions to Common Chemotherapeutic Agents.
    Iemmolo R; La Cognata V; Morello G; Guarnaccia M; Arbitrio M; Alessi E; Cavallaro S
    Biosensors (Basel); 2020 Dec; 10(12):. PubMed ID: 33317085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of pharmacogenetics in cancer therapeutics.
    Yong WP; Innocenti F; Ratain MJ
    Br J Clin Pharmacol; 2006 Jul; 62(1):35-46. PubMed ID: 16842377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer pharmacogenetics.
    Marsh S; McLeod HL
    Br J Cancer; 2004 Jan; 90(1):8-11. PubMed ID: 14710198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Application of Pharmacogenomics in Oncology.
    Zhang Y; Somtakoune SD; Cheung C; Listiawan M; Feng X
    AAPS J; 2016 Jul; 18(4):819-29. PubMed ID: 27178043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy.
    Robert J
    J Chemother; 2004 Nov; 16 Suppl 4():22-4. PubMed ID: 15688604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomics in cancer therapy: is host genome variability important?
    Petros WP; Evans WE
    Trends Pharmacol Sci; 2004 Sep; 25(9):457-64. PubMed ID: 15559247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value and applications of pharmacogenetics in oncology and hematology].
    Albin N; Massade L; Gouyette A
    Bull Cancer; 1997 Jun; 84(6):643-51. PubMed ID: 9295869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy.
    Robaey P; Krajinovic M; Marcoux S; Moghrabi A
    Dev Disabil Res Rev; 2008; 14(3):211-20. PubMed ID: 18924160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.
    Phan VH; Tan C; Rittau A; Xu H; McLachlan AJ; Clarke SJ
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1395-410. PubMed ID: 21950349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of pharmacogenetics in chemotherapy of colorectal cancers].
    Ceppa F; Fontan E; Cremades S; Bihannic R; Bousquet A; Beauvillain L; Burnat P
    Rev Med Interne; 2007 Sep; 28(9):594-602. PubMed ID: 17624636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
    Lee W; Lockhart AC; Kim RB; Rothenberg ML
    Oncologist; 2005 Feb; 10(2):104-11. PubMed ID: 15709212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
    Ahmed S; Zhou Z; Zhou J; Chen SQ
    Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):298-313. PubMed ID: 27729266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PharmFrag: An Easy and Fast Multiplex Pharmacogenetics Assay to Simultaneously Analyze 9 Genetic Polymorphisms Involved in Response Variability of Anticancer Drugs.
    Bouvet R; Verdier MC; El Baroudi Y; Galibert MD; David V; Schutz S; Tron C
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics and pediatric cancer.
    Bomgaars L; McLeod HL
    Cancer J; 2005; 11(4):314-23. PubMed ID: 16197721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of genetic factors on platinum-induced gastrointestinal toxicity.
    Zheng Y; Deng Z; Tang M; Xiao D; Cai P
    Mutat Res Rev Mutat Res; 2020; 786():108324. PubMed ID: 33339576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetics in gastrointestinal tumors.
    Stöhlmacher J
    Onkologie; 2005 Aug; 28(8-9):435-40. PubMed ID: 16160407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics and adverse drug reactions.
    Meyer UA
    Lancet; 2000 Nov; 356(9242):1667-71. PubMed ID: 11089838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical association between pharmacogenomics and adverse drug reactions.
    Zhou ZW; Chen XW; Sneed KB; Yang YX; Zhang X; He ZX; Chow K; Yang T; Duan W; Zhou SF
    Drugs; 2015 Apr; 75(6):589-631. PubMed ID: 25895462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.